Status:
COMPLETED
Remote Neurobased Approach to Aphasia Therapy
Lead Sponsor:
Institute for Bioengineering of Catalonia
Collaborating Sponsors:
Hospital Universitari Joan XXIII de Tarragona.
Universitat Pompeu Fabra
Conditions:
Aphasia, Broca
Aphasia, Wernicke
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The purpose of this study is the development and validation of an evidence-based mobile application, based on the core premises of Intensive Language-Action Therapy (ILAT) for aphasia, for the trainin...
Detailed Description
Acquired brain lesions such as stroke often result in the most common disabling neurological damages. Up to 42% of stroke patients suffer serious language deficits and patients are frequently left wit...
Eligibility Criteria
Inclusion
- Patients with any type of aphasia
- 6 or more months have passed since the stroke (chronic stage)
- Age between 18 and 90 years
Exclusion
- Non-compliance with some of the inclusion criteria
- Presence of major perceptual, cognitive, motor, cognitive or neuropsychological pathology that can interfere with aphasia or make it difficult to interact with the system, including severe forms of motor impairments and apraxia, visual processing deficits, planning deficits, learning deficits, memory deficits, or attentional deficits
- Inability to understand the study participation
- Patients with an Android phone or tablet
Key Trial Info
Start Date :
November 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 29 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05274360
Start Date
November 29 2021
End Date
December 29 2021
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Bioengineering of Catalonia - Specs Lab
Barcelona, Spain, 08930